Skip to main content
Premium Trial:

Request an Annual Quote

Capello Resigns as PerkinElmer CFO, NextGen Appoints Biomarker Execs, and Others

NEW YORK (GenomeWeb News) - PerkinElmer said this week that Jeff Capello has resigned as the company’s CFO, effective June 6, to pursue other interests.
Michael Battles will replace Capello on an interim basis. Battles is currently the company’s vice president and controller.
Capello joined PerkinElmer in 2001 as controller for the analytical Instruments business. Prior to that, he held several positions at Deloitte & Touche.

NextGen Sciences has appointed Ruth VanBogelen and Walid Qoronfleh to executive positions in its protein biomarker team as part of a strategy to focus on biomarker services. The company has named VanBogelento the role of director of biomarkers and proteomics, and Qoronfleh to be VP of business development.
VanBogelencomes to NextGen from Pfizer, where she also served as director of proteomics R&D, and she has thirty years of experience in proteomics, including leading microbial proteomics studies at the University of Michigan Medical Center.
Qoronfleh previously was founder and managing director of Q3 Consulting Group, and he spent twenty years holding various executive positions at AntexPharma, Pierce Biotechnology, and at CTA Corp/University of Michigan-Ann Arbor. He also held scientific and R&D appointments at SmithKline Beecham, Sterling Winthrop Pharmaceuticals, and at the National Cancer Institute.

The UK molecular diagnostics company Myconostica has tapped David Holbrook, manager of new Myconostica investor the UMIP Premier Fund, to join the company’s board of directors.
Holbrook has worked in hospital medicine and in business development and licensing in the pharmaceutical industry.

HTG has appointed Billie-Jo Kerns to be VP of strategic marketing and business development.
Kerns has “more than twenty seven years of marketing and business development experience along with a successful track record in diagnostics,” HTG CEO TJ Johnson said this week.
Kerns formerly was director of integrated solutions and molecular diagnostics at Promega, and was director of women’s health, director of strategic marketing, and senior director of technical support at Ventana Medical Systems.

NightHawk Radiology Holdings has appointed David Sankaran to senior vice president and chief financial officer.
Sankaran was previously senior vice president and chief financial officer of Accelrys.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.